Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer

Clinical trial NCT01548144 · TERMINATED

Trial details

NCT number: NCT01548144
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2012-04-01
Primary completion: 2021-08-26
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.